当前位置：
X-MOL 学术
›
Expert Rev. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Efficacy and safety of tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials
Expert Review of Gastroenterology & Hepatology ( IF 3.9 ) Pub Date : 2023-10-24 , DOI: 10.1080/17474124.2023.2267421 Lu Chai 1, 2 , Zhe Li 1, 2 , Ting Wang 1, 2 , Ran Wang 1 , Kanokwan Pinyopornpanish 3 , Gang Cheng 2 , Xingshun Qi 1, 2
Expert Review of Gastroenterology & Hepatology ( IF 3.9 ) Pub Date : 2023-10-24 , DOI: 10.1080/17474124.2023.2267421 Lu Chai 1, 2 , Zhe Li 1, 2 , Ting Wang 1, 2 , Ran Wang 1 , Kanokwan Pinyopornpanish 3 , Gang Cheng 2 , Xingshun Qi 1, 2
Affiliation
Tolvaptan has been approved for the management of cirrhosis-related complications according to the Japanese and Chinese practice guidelines, but not the European or American practice guidelines in ...
更新日期：2023-10-28
京公网安备 11010802027423号